Enzene Biosciences funding, investors and company details

Enzene Biosciences is an emerging Pharmaceutical startup from Mumbai, working in the space of Biotechnology company focused on biologics and biosimilars, established with the goal of making affordable biologics widely accessible through advanced continuous manufacturing technologies.. Founded by Himanshu Gadgil.

Company: Enzene Biosciences Limited
Sector: Pharmaceutical
Location: Mumbai
Founders: Himanshu Gadgil
Total funding raised: ₹408.7 Cr

Company overview

Enzene Biosciences is a biotechnology company focused on biologics and biosimilars, established with the goal of making affordable biologics widely accessible through advanced continuous manufacturing technologies. Its mission is to transform biologics production by combining innovation, efficiency, and cost-effectiveness, positioning the company as a leader in both biosimilars and novel biologics. Operating as a Continuously Innovative Development & Manufacturing Organization (CIDMO), Enzene provides end-to-end CDMO services spanning molecular biology, protein expression, fermentation, bioanalytics, immunology, and peptide synthesis. This integrated capability enables support from early-stage development through to large-scale commercial manufacturing. The company has built proprietary platforms for upstream and downstream process development, allowing for faster and more economical biologics production. With expertise across microbial, insect, and mammalian cell systems, Enzene offers flexibility across a broad range of therapeutic modalities.

Funding rounds

Latest round: $ 50.00 Mn (₹408.70 Cr.), 2023-01-30. Investors: Alkem Laboratories, Eight Roads ventures, F-Prime